abrilumab: Clinical Trials

3 trials of abrilumab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3

Follow abrilumab: new trials by email Literature Review of abrilumab trials Research Report on abrilumab

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
MEDI7183 Phase 2 Study in Japanese Ulcerative Colitis Patients
MEDI7183 low dose, MEDI7183 medium dose, MEDI7183 high dose - Ulcerative Colitis
Phase 2CompletedAstraZeneca442013-11-212019-07-05
Abrilumab (AMG 181) in Adults With Moderate to Severe Crohn's Disease
Abrilumab, Placebo - Crohn's Disease
Phase 2CompletedAmgen2542012-12-042019-06-27
Abrilumab (AMG 181) in Adults With Moderate to Severe Ulcerative Colitis
Abrilumab, Placebo - Ulcerative Colitis
Phase 2CompletedAmgen3592012-11-162019-06-27

Conditions studied

Colitis, Ulcerative (2)  ·  Crohn Disease (1)

Sponsors

Amgen (2)  ·  AstraZeneca (1)

Countries

Austria (2)  ·  Belgium (2)  ·  Canada (2)  ·  Czechia (2)  ·  Denmark (2)  ·  France (2)  ·  Germany (2)  ·  Hungary (2)  ·  Netherlands (2)  ·  Switzerland (2)  ·  United Kingdom (2)  ·  United States (2)  ·  Australia (1)  ·  Estonia (1)  ·  Greece (1)

Top investigators

Ki Rito, Study Physician (1)  ·  Toshifumi Hibi, Director and Professor (1)

Results publications

PMID 30472236